Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
伊沙妥昔单抗皮下注射联合卡非佐米和地塞米松治疗复发/难治性多发性骨髓瘤患者的疗效和安全性:II期研究IZALCO的结果
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01436-0
Parmar, Gurdeep; Capra, Marcelo; Seguro, Fernanda; Hungria, Vania; Dimopoulos, Meletios-Athanasios; Delimpasi, Sosana; Minařík, Jiří; Špička, Ivan; Pour, Luděk; Marques, Herlander; Esteves, Graça; Sunami, Kazutaka; Yuda, Junichiro; Hájek, Roman; Mihályová, Jana; Soufflet, Christine; Yu, Disa; Benlhassan, Khadija; Koch, Victorine; Comerford, Erin; Cordero, Paul; Suzan, Florence; Quach, Hang